Download Files:
CEP-28122
SKU
HY-18030-Get quote
Category Reference compound
Tags Anaplastic lymphoma kinase (ALK), Cancer, Protein Tyrosine Kinase/RTK
Web ID
– HY-18030
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C28H35ClN6O3
References
– [1]Cheng M, et al. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers. Mol Cancer Ther. 2012 Mar;11(3):670-679.
CAS Number
– 1022958-60-6
Molecular Weight
– 539.07
SMILES
– O=C([C@H]1[C@](C2)([H])C=C[C@]2([H])[C@H]1NC3=NC(NC4=CC=C5C(CC[C@@H](N6CCOCC6)CC5)=C4OC)=NC=C3Cl)N
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Anaplastic lymphoma kinase (ALK)
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.